PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 175 filers reported holding PTC THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $497,231 | +1971.8% | 16,260 | +1870.9% | 0.01% | +700.0% |
Q1 2024 | $24,000 | -86.9% | 825 | -87.6% | 0.00% | -50.0% |
Q4 2023 | $183,219 | +244.1% | 6,648 | +179.8% | 0.00% | 0.0% |
Q3 2023 | $53,246 | -87.4% | 2,376 | -77.1% | 0.00% | -85.7% |
Q2 2023 | $421,301 | +221637.4% | 10,359 | +164.1% | 0.01% | +133.3% |
Q1 2023 | $190 | +143.6% | 3,922 | +92.2% | 0.01% | +100.0% |
Q4 2022 | $78 | -100.0% | 2,041 | -92.9% | 0.00% | -87.0% |
Q3 2022 | $1,438,000 | +63.0% | 28,635 | +30.2% | 0.02% | +15.0% |
Q2 2022 | $882,000 | +237.9% | 22,000 | +213.5% | 0.02% | +900.0% |
Q1 2022 | $261,000 | -39.6% | 7,018 | -35.3% | 0.00% | -71.4% |
Q4 2021 | $432,000 | +99.1% | 10,842 | +86.4% | 0.01% | +16.7% |
Q3 2021 | $217,000 | -15.9% | 5,815 | -4.7% | 0.01% | -14.3% |
Q2 2021 | $258,000 | -28.1% | 6,100 | -19.6% | 0.01% | +16.7% |
Q1 2021 | $359,000 | +136.2% | 7,586 | +205.5% | 0.01% | +20.0% |
Q4 2020 | $152,000 | +46.2% | 2,483 | +11.3% | 0.01% | +400.0% |
Q3 2020 | $104,000 | -71.4% | 2,230 | -68.9% | 0.00% | -93.3% |
Q2 2020 | $364,000 | +18100.0% | 7,169 | +18282.1% | 0.02% | – |
Q4 2019 | $2,000 | -98.5% | 39 | -99.0% | 0.00% | -100.0% |
Q3 2019 | $130,000 | +80.6% | 3,843 | +82.5% | 0.01% | +80.0% |
Q4 2018 | $72,000 | +380.0% | 2,106 | +376.5% | 0.01% | +400.0% |
Q2 2018 | $15,000 | -92.5% | 442 | -94.0% | 0.00% | -94.1% |
Q1 2018 | $199,000 | +729.2% | 7,356 | +420.6% | 0.02% | +466.7% |
Q4 2017 | $24,000 | +118.2% | 1,413 | +155.1% | 0.00% | +200.0% |
Q3 2017 | $11,000 | -81.7% | 554 | -89.9% | 0.00% | -85.7% |
Q4 2016 | $60,000 | +900.0% | 5,510 | +512.2% | 0.01% | +600.0% |
Q2 2016 | $6,000 | +500.0% | 900 | +350.0% | 0.00% | – |
Q1 2016 | $1,000 | -96.4% | 200 | -76.9% | 0.00% | -100.0% |
Q4 2015 | $28,000 | -58.2% | 867 | -37.5% | 0.01% | -16.7% |
Q2 2015 | $67,000 | -40.2% | 1,387 | -24.5% | 0.01% | -57.1% |
Q1 2015 | $112,000 | +11100.0% | 1,836 | +4862.2% | 0.01% | – |
Q2 2014 | $1,000 | -85.7% | 37 | -90.8% | 0.00% | -100.0% |
Q4 2013 | $7,000 | -65.0% | 400 | -57.3% | 0.00% | -50.0% |
Q3 2013 | $20,000 | – | 937 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |